TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioRent Skandinavien AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
360
|
269
|
238 |
Financial expenses |
2
|
1
|
0 |
Earnings before taxes |
0
|
7
![]() |
7 |
EBITDA |
9
|
12
|
7 |
Total assets |
106
|
79
|
63 |
Current assets |
82
|
62
|
63 |
Current liabilities |
73
|
50
![]() |
50 |
Equity capital |
15
|
16
|
12 |
- share capital |
5
|
4
|
5 |
Employees (average) |
6
|
5
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
14.2%
|
20.3%
|
19.0% |
Turnover per employee |
60
|
54
|
79 |
Profit as a percentage of turnover |
0%
|
2.6%
|
2.9% |
Return on assets (ROA) |
1.9%
|
10.1%
|
11.1% |
Current ratio |
112.3%
|
124.0%
|
126.0% |
Return on equity (ROE) |
0%
|
43.8%
|
58.3% |
Change turnover |
90
|
51
|
92 |
Change turnover % |
33%
|
23%
|
63% |
Chg. No. of employees |
1
|
2
|
-3 |
Chg. No. of employees % |
20%
|
67%
|
-50% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.